Pharmaceutical Executive January 15, 2024
Each program strengthens the pharma value chain, impacting the core areas of clinical development, supply chain, and manufacturing and commercial engagement.
One prediction for 2024 that may go unnoticed but should not is that the top players in pharma will begin to scale up the results they’re getting with data, digital, and artificial intelligence (AI). The idea of scale—taking the innovations that only happen in some parts of an organization and helping them happen elsewhere—is not a novel one, but it’s still an essential concept when it comes to generating value for an organization.
When we consider the idea of scale from the viewpoint of operating income, for example, we estimate that growing seven tested digital programs could generate $1.4...
Today's Sponsors
Today's Sponsor